United Therapeutics Statistics
Total Valuation
UTHR has a market cap or net worth of $14.60 billion. The enterprise value is $12.50 billion.
| Market Cap | 14.60B |
| Enterprise Value | 12.50B |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, before market open.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
UTHR has 44.37 million shares outstanding. The number of shares has increased by 0.20% in one year.
| Shares Outstanding | 44.37M |
| Shares Change (YoY) | +0.20% |
| Shares Change (QoQ) | -0.60% |
| Owned by Insiders (%) | 1.85% |
| Owned by Institutions (%) | 104.75% |
| Float | 40.66M |
Valuation Ratios
The trailing PE ratio is 15.59 and the forward PE ratio is 11.62. UTHR's PEG ratio is 7.80.
| PE Ratio | 15.59 |
| Forward PE | 11.62 |
| PS Ratio | 5.85 |
| Forward PS | 4.96 |
| PB Ratio | 2.74 |
| P/FCF Ratio | 19.41 |
| PEG Ratio | 7.80 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.36, with an EV/FCF ratio of 16.61.
| EV / Earnings | 11.90 |
| EV / Sales | 5.00 |
| EV / EBITDA | 8.36 |
| EV / EBIT | 8.68 |
| EV / FCF | 16.61 |
Financial Position
The company has a current ratio of 3.78, with a Debt / Equity ratio of 0.11.
| Current Ratio | 3.78 |
| Quick Ratio | 3.50 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.40 |
| Debt / FCF | 0.80 |
| Interest Coverage | 24.49 |
Financial Efficiency
Return on equity (ROE) is 18.70% and return on invested capital (ROIC) is 16.10%.
| Return on Equity (ROE) | 18.70% |
| Return on Assets (ROA) | 15.40% |
| Return on Capital (ROIC) | 16.10% |
| Revenue Per Employee | $2.14M |
| Profits Per Employee | $899,401 |
| Employee Count | 1,168 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.50 |
Taxes
In the past 12 months, UTHR has paid $330.50 million in taxes.
| Income Tax | 330.50M |
| Effective Tax Rate | 23.93% |
Stock Price Statistics
The stock price has increased by +35.91% in the last 52 weeks. The beta is 0.56, so UTHR's price volatility has been lower than the market average.
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +35.91% |
| 50-Day Moving Average | 294.60 |
| 200-Day Moving Average | 246.29 |
| Relative Strength Index (RSI) | 69.42 |
| Average Volume (20 Days) | 576,062 |
Short Selling Information
The latest short interest is 4.41 million, so 9.94% of the outstanding shares have been sold short.
| Short Interest | 4.41M |
| Short Previous Month | 4.37M |
| Short % of Shares Out | 9.94% |
| Short % of Float | 10.85% |
| Short Ratio (days to cover) | 6.41 |
Income Statement
In the last 12 months, UTHR had revenue of $2.50 billion and earned $1.05 billion in profits. Earnings per share was $21.12.
| Revenue | 2.50B |
| Gross Profit | 2.22B |
| Operating Income | 1.26B |
| Pretax Income | 1.38B |
| Net Income | 1.05B |
| EBITDA | 1.49B |
| EBIT | 1.44B |
| Earnings Per Share (EPS) | $21.12 |
Balance Sheet
The company has $2.71 billion in cash and $600.00 million in debt, giving a net cash position of $2.11 billion or $47.51 per share.
| Cash & Cash Equivalents | 2.71B |
| Total Debt | 600.00M |
| Net Cash | 2.11B |
| Net Cash Per Share | $47.51 |
| Equity (Book Value) | 5.34B |
| Book Value Per Share | 120.32 |
| Working Capital | 2.39B |
Cash Flow
In the last 12 months, operating cash flow was $979.70 million and capital expenditures -$227.30 million, giving a free cash flow of $752.40 million.
| Operating Cash Flow | 979.70M |
| Capital Expenditures | -227.30M |
| Free Cash Flow | 752.40M |
| FCF Per Share | $16.01 |
Margins
Gross margin is 88.87%, with operating and profit margins of 50.31% and 42.05%.
| Gross Margin | 88.87% |
| Operating Margin | 50.31% |
| Pretax Margin | 55.28% |
| Profit Margin | 42.05% |
| EBITDA Margin | 59.83% |
| EBIT Margin | 57.63% |
| FCF Margin | 30.12% |
Dividends & Yields
UTHR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.20% |
| Shareholder Yield | -0.20% |
| Earnings Yield | 7.19% |
| FCF Yield | 5.15% |
Analyst Forecast
The average price target for UTHR is $319.25, which is -3.01% lower than the current price. The consensus rating is "Buy".
| Price Target | $319.25 |
| Price Target Difference | -3.01% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 9.13% |
| EPS Growth Forecast (5Y) | 6.87% |
Stock Splits
The last stock split was on September 23, 2009. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 23, 2009 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
UTHR has an Altman Z-Score of 10.5 and a Piotroski F-Score of 5.
| Altman Z-Score | 10.5 |
| Piotroski F-Score | 5 |